Using a Cold Atmospheric Plasma Device to Treat Skin Disorders
1 other identifier
interventional
100
1 country
1
Brief Summary
This study examines the efficacy of a non-thermal, atmospheric plasma device in the treatment of skin disorders
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2016
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2016
CompletedFirst Submitted
Initial submission to the registry
April 26, 2016
CompletedFirst Posted
Study publicly available on registry
May 3, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2025
CompletedApril 12, 2022
April 1, 2022
8.2 years
April 26, 2016
April 10, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Clinical improvement
The outcome is the presence or lack of clinical improvement in the investigator's global assessment and reviewing photo-documentation as well as reflectance confocal microscopy study investigator's global assessment and reviewing photo-documentation
1-12 months
Study Arms (2)
Non-thermal atmospheric plasma treatment
EXPERIMENTALDevice treatment
Indirect non-thermal atmospheric plasma treatment
EXPERIMENTALA compound of non-thermal atmospheric plasma and medium is used to treat the target by direct application or by on-site generation of the compound
Interventions
Non-thermal, atmospheric plasma treatment of affected area or lesions using a nanosecond dielectric barrier discharge plasma device
A compound of non-thermal, atmospheric plasma and medium is delivered to or generated at the target area. Plasma is generated using either microsecond dielectric barrier discharge plasma device or PiezoBrush (a helium jet plasma). The medium is an aqueous alcohol solution
Eligibility Criteria
You may qualify if:
- diagnoses of target conditions
- ability to complete study protocol
You may not qualify if:
- based on specific condition
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Skin Center Dermatology Group
New City, New York, 10956, United States
Related Publications (2)
Friedman PC, Fridman G, Fridman A. Cold atmospheric pressure plasma clears molluscum contagiosum. Exp Dermatol. 2023 Apr;32(4):562-563. doi: 10.1111/exd.14695. Epub 2022 Nov 3. No abstract available.
PMID: 36302167DERIVEDMalik S, Gill M, Fridman G, Fridman A, Friedman PC. Cold atmospheric plasma reduces demodex count on the face comparably to topical ivermectin, as measured by reflectance confocal microscopy. Exp Dermatol. 2022 Sep;31(9):1352-1354. doi: 10.1111/exd.14584. Epub 2022 May 11. No abstract available.
PMID: 35491738DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 26, 2016
First Posted
May 3, 2016
Study Start
January 1, 2016
Primary Completion
March 1, 2024
Study Completion
January 1, 2025
Last Updated
April 12, 2022
Record last verified: 2022-04